1 min read
Add as a preferred source on GoogleOpus Genetics’ Third-Quarter Loss Widens to $46.5 Million
The company recorded a $0.46 loss per share, compared with $0.25 a year earlier. Revenue fell to $1.14 million from $3.08 million.
Opus Genetics posted a $46.5 million net loss for the quarter ended Sept. 30, 2026, as its loss widened from a year earlier and revenue fell to $1.14 million.
The net loss was $46.5 million, or $0.46 per share, compared with $17.5 million, or $0.25 per share, in the same quarter of 2025.
Revenue totaled $1.14 million, down from $3.08 million in the year-earlier quarter.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.